Results 71 to 80 of about 2,363,412 (175)
Aspirin resistance Aspirin Direnci
Aspirin is an effective antithrombotic agent for many patients. However, patients taking aspirin might exhibit variable responses to in vitro tests for platelet aggregation and might experience breakthrough thromboembolic events. Although this phenomenon
YILMAZ, MEHMET BİRHAN +2 more
core
Aspirin is a non-steroidal anti-inflammatory drug. It is used for the prevention of thrombo-embolism in patients at risk for getting them.Aspirin resistance is a term coined from people who take aspirin and still get thrombo-embolism.
Ehinmisan, Ayara Onome
core
Background: Coronary artery disease (CAD) and myocardial infarction are the most common cause of mortality and morbidity all over the world..
Naghmeh Ziaie +5 more
doaj
Multidrug Resistance Protein-4 Influences Aspirin Toxicity in Human Cell Line
Overexpression of efflux transporters, in human cells, is a mechanism of resistance to drug and also to chemotherapy. We found that multidrug resistance protein-4 (MRP4) overexpression has a role in reducing aspirin action in patients after bypass ...
Isabella Massimi +6 more
doaj +1 more source
The aim of this study was to evaluate the prevalence of aspirin resistance (AR) in patients undergoing hemodialysis (HD) and to assess the effect of HD on the results of the Multiplate test. A total of 54 patients undergoing HD were included in this study. Blood samples were taken just before and after the HD session.
Hale Unal, Aksu +9 more
openaire +2 more sources
In this open, prospective study we assessed the prevalence of antiplatelet resistance among patients subjected to intracoronary stent implantation. In patients treated with aspirin + thienopyridine (N = 32), platelet reactivity index (PRI) significantly ...
Nina Djukanovic +5 more
doaj +1 more source
Aspirin: promise and resistance in the new millennium.
Although conceived at the end of the 19th century, aspirin remains the gold standard of antiplatelet therapy. Approximately 100 randomized clinical trials have established its efficacy and safety in the prevention of myocardial infarction, ischemic ...
Patrono, Carlo, Rocca, Bianca
core
Aspirin resistance in systemic lupus erythematosus. A pilot study
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients.
Ertenli, I. +8 more
core +1 more source
Does high serum uric acid level cause aspirin resistance?
In patients with coronary artery disease (CAD), though aspirin inhibits platelet activation and reduces atherothrombotic complications, it does not always sufficiently inhibit platelet function, thereby causing a clinical situation known as aspirin ...
Kılıç, İsmail Doğu +6 more
core +1 more source
ACETYLSALICYLIC ACID RESISTANCE: RISK FACTORS, MECHANISMS, DIAGNOSTIC TESTS
Acetylsalicylic acid (aspirin) is one the most widespread drugs in the world. It is used for secondary prevention of atherothrombotic events in patients with cardiovascular disease.
K.Yu. Lukianets, I.Yu. Pchelin
doaj

